Abstract
BackgroundCheckpoint inhibitor (CPI) antibodies induce blockade of CTLA-4 and PD-1 to reinvigorate the immune system to induce tumor cell clearance. Despite the success of CPI in cancer treatment, CPIs often...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have